Thu, Dec 25, 2014, 12:59 PM EST - U.S. Markets closed for Christmas


% | $
Quotes you view appear here for quick access.

IntelliCell BioSciences, Inc. Message Board

ipstissueface 26 posts  |  Last Activity: 23 hours ago Member since: Oct 25, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • ALAMEDA, Calif.--(BUSINESS WIRE)--Oct. 1, 2014-- BioTime, Inc. (NYSE MKT:BTX) and its subsidiary LifeMap Solutions, Inc., a medical technology company, today announced significant additions to the LifeMap Solutions management team. LifeMap Solutions is partnering with the Icahn Institute at Mount Sinai to create innovative mobile health (mHealth) products and services backed by big data. Today the company announced the appointment of Rafhael Cedeno as Chief Technology Officer and Head of Product, as well as the addition of Joel Dudley, PhD, Rong Chen, PhD, and Elissa Levin from the Icahn Institute as members of the LifeMap Solutions science team.

    A veteran in big data and consumer technology applications, Rafhael Cedeno comes to LifeMap Solutions with significant experience at Internet and software companies, including his previous role as Vice President of Game Development for Viacom, where he oversaw the development of top-charting iOS and Android apps on the Apple App Store and Google Play, respectively, and provided technical and product direction for other projects at Viacom. Earlier in his career, Mr. Cedeno worked at such influential Internet companies as Netscape and Kontiki. As Chief Technology Officer and Head of Product, Mr. Cedeno will be responsible for overseeing all aspects of product development, including the integration of Mount Sinai's expertise and data into LifeMap Solutions' products.

    "Adding Rafhael Cedeno to our team is a major win for us," said LifeMap Solutions CEO Corey Bridges. "He brings to LifeMap Solutions his experience architecting and managing the development of complex technology platforms, coupled with the bold innovation he applies to product design. His history of success in the mobile space meshes perfectly with our needs."

    "This is an exciting time to work in health technology. We are living in an era characterized by an unprecedented ability to analyze enormous quantities of data from sources that weren't easily accessible previously," said Mr. Cedeno. "As we work alongside our partners at Mount Sinai, we are uniquely poised to make an impact in the industry."

    In addition, LifeMap Solutions today announced the names of the new members of the company's science team from their partner, the Icahn Institute at Mount Sinai:

    Joel Dudley, PhD, Director of Biomedical Informatics
    Elissa Levin, MS, CGC, Head of Genomics and Integrative Health Innovations
    Rong Chen, PhD, Director of Clinical Genome Informatics
    Eric Schadt, PhD, founding director of the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai, was previously announced as the leading science advisor to LifeMap Solutions. The science team will coordinate with Mr. Cedeno to share knowledge and expertise to build mHealth products and services.

  • Reply to

    Many will regret not being in this one...-

    by kipk20122 Sep 30, 2014 2:28 PM
    ipstissueface ipstissueface Sep 30, 2014 7:31 PM Flag

    Dr. West stated BTX will achieve multiple milestones by years end, this means LlifeMap App 1.0, multiple PanC-DX products, Renevia ok'd...

  • PanC-DX announcements of positive results/release dates/partners will give us a good pop.
    $9-12 is not out of the question since these products will replace current test within a billion dollar market.

  • Reply to

    Biotime owns 75% of OncoCyte

    by drwestclone Sep 29, 2014 5:41 PM
    ipstissueface ipstissueface Sep 29, 2014 10:28 PM Flag

    Check out the OncoCyte video on the BTX website....PanC-DX has 100 more genetic markers then the current diagnostic tests! Gonna blow the roof off of the industry.

  • ipstissueface by ipstissueface Sep 26, 2014 1:05 AM Flag

    BTX go boom

  • ipstissueface by ipstissueface Sep 25, 2014 9:18 PM Flag

    Mothership BTX is half the price! Cancer diagnostic update Monday. Win-Win

0.00019-0.00001(-5.00%)Dec 24 12:55 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Yahoo! Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Noble Energy, Inc.
NYSEWed, Dec 24, 2014 2:48 PM EST